GelStat Corp(GSAC)
USD --+0.00%
Reward52Moderate
Risk93High
📊75%Data
Thin -78% profit margin
GSAC
+0.0 · +0.00%
USD · PINK
GelStat Corp | Technology
Speculative Momentum
Market Cap:510188
ℹ️
Reward Rating
52
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
93
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on GSAC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is GelStat Corp?

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

GSAC · Verdict

Moderate reward · high risk

GSAC has limited near-term tailwinds — volatility and balance sheet weigh on the model output.

Based on 88% data coverage

GSAC · Verdict

What’s working & what to watch

Watchouts 4

  • Volatility5/100

    Weak vs peers

  • Balance sheet6/100

    Current ratio 0.07

  • Cash flow6/100

    -16% free-cash-flow margin

  • Profitability32/100

    -107% net margin · -27% ROE

Model-based scoring. For information only — not financial advice.

What is GelStat Corp?

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company is listed on the PINK in USA, operating in the Technology sector, with a market capitalisation of 510.19K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (52)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorTechnology
Market Cap510.19K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0005
52 Week Low0.0002
Last AnnualDecember
IPO Date4/23/1993
IncorporatedUSA
Shares OutstandingN/A
No. of Employees2
IndustrySoftware - Infrastructure
ExchangePINK
Beta2.967
CurrencyUSD